Description

Bausch + Lomb: Innovative Product Launches in the Surgical Business Can Truly Shape Their Future! 

Bausch + Lomb delivered a robust financial performance in the fourth quarter of 2024, marking its fifth consecutive quarter of double-digit constant currency revenue growth. The company achieved a 17% growth in constant currency revenue for the entire year. This trajectory is attributed to the continuous introduction of new products and substantial enhancements in manufacturing processes, notably through the deployment of AI technologies.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!